ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 188 filers reported holding ACORDA THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 90 | -18.2% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 110 | -84.2% | 0.00% | -100.0% |
| Q1 2019 | $18,000 | -5.3% | 698 | -45.2% | 0.00% | -55.6% |
| Q4 2018 | $19,000 | -20.8% | 1,273 | +2.6% | 0.01% | -10.0% |
| Q3 2018 | $24,000 | -35.1% | 1,241 | -5.2% | 0.01% | -37.5% |
| Q2 2018 | $37,000 | +15.6% | 1,309 | -3.6% | 0.02% | +23.1% |
| Q1 2018 | $32,000 | +14.3% | 1,358 | +1.4% | 0.01% | +18.2% |
| Q4 2017 | $28,000 | -28.2% | 1,339 | -19.4% | 0.01% | -47.6% |
| Q3 2017 | $39,000 | +62.5% | 1,662 | +33.1% | 0.02% | +61.5% |
| Q2 2017 | $24,000 | +60.0% | 1,249 | +69.9% | 0.01% | +62.5% |
| Q1 2017 | $15,000 | +1400.0% | 735 | +1212.5% | 0.01% | +700.0% |
| Q3 2016 | $1,000 | 0.0% | 56 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $1,000 | -66.7% | 56 | -60.0% | 0.00% | -50.0% |
| Q1 2016 | $3,000 | -57.1% | 140 | -23.1% | 0.00% | -50.0% |
| Q4 2015 | $7,000 | – | 182 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 325,000 | $8,289,000 | 2.39% |
| ARMISTICE CAPITAL, LLC | 232,000 | $5,917,000 | 2.25% |
| SENZAR ASSET MANAGEMENT, LLC | 358,191 | $9,135,662,000 | 1.99% |
| SCOPIA CAPITAL MANAGEMENT LP | 3,171,229 | $80,882,000 | 1.67% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,029,410 | $26,255,000 | 1.03% |
| Baker Brothers Advisors | 3,661,082 | $93,376,000 | 0.98% |
| ARBOR CAPITAL MANAGEMENT LLC | 58,783 | $1,499,000 | 0.79% |
| Spark Investment Management LLC | 292,400 | $7,457,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 98,000 | $2,499,000 | 0.65% |
| Virtus ETF Advisers LLC | 21,130 | $539,000 | 0.40% |